Feb 25, 2026 06:55AM
Feb 25, 2026 06:55AM
Feb 12, 2026 07:30AM
Feb 12, 2026 07:30AM
Jan 6, 2026 07:04AM
Jan 6, 2026 07:00AM
Nov 19, 2025 06:00AM Alkermes increases Avadel acquisition offer to $22.50 per share
Nov 19, 2025 06:00AM
Nov 17, 2025 05:52AM
Nov 17, 2025 05:45AM
Nov 14, 2025 05:45AM
Nov 14, 2025 05:45AM
Nov 12, 2025 09:57AM
Oct 28, 2025 07:00AM Alkermes plc Reports Third Quarter 2025 Financial Results
Oct 22, 2025 07:00AM
Oct 22, 2025 07:00AM
Sep 10, 2025 09:16AM
Jul 29, 2025 07:00AM
Jun 2, 2025 07:00AM
May 1, 2025 07:00AM
Feb 12, 2025 07:00AM Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2024 and Provides Financial Expectations for 2025
Jan 29, 2025 09:12AM
Jan 6, 2025 10:35AM
Jan 2, 2025 01:02PM
Oct 24, 2024 07:00AM
Jul 24, 2024 07:00AM
May 14, 2024 07:00AM
May 1, 2024 07:00AM Alkermes plc Reports First Quarter 2024 Financial Results
Apr 8, 2024 07:22AM
Apr 8, 2024 07:00AM
Feb 15, 2024 07:00AM
Jan 3, 2024 07:03AM
Jan 3, 2024 07:00AM
Nov 15, 2023 07:00AM
Oct 25, 2023 07:00AM Alkermes plc Reports Third Quarter 2023 Financial Results
Jul 26, 2023 07:00AM
Jun 29, 2023 10:50AM
Jun 29, 2023 10:50AM
Jun 26, 2023 07:00AM
Jun 21, 2023 08:00AM
Jun 20, 2023 07:00AM
Jun 13, 2023 07:05AM Alkermes (ALKS) Issues Letter to Shareholders
Jun 13, 2023 07:00AM
Jun 8, 2023 07:00AM
Jun 6, 2023 06:00AM
Jun 1, 2023 04:01PM
Jun 1, 2023 04:01PM
May 25, 2023 04:15PM
May 9, 2023 07:00AM Alkermes Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 26, 2023 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All